Back to the complete issue
Tuesday, 30 March 2021

Because covid news never, ever ends…

The border with Israel at Taba has reopened for vaccinated Israelis, with some 300 people per day now crossing, reports i24 News. Visitors coming over to hit the beach will need to show a negative PCR tests on arrival in Egypt and return to Israel. The current rules will remain in place until 12 April with the possibility of increasing the number of people allowed to pass. The passage is popular with Israelis who travel to Sinai for vacation.

World leaders agree to create international treaty to avoid covid-esque situations in the future: The World Health Organization (WHO) and 23 countries have agreed to draw up an international treaty outlining cooperation in the case of future health emergencies, according to Reuters. The treaty has the aim of ensuring universal and equitable access to vaccines, medicines and diagnostics for pandemics as “no single government or multilateral agency can address this threat alone.”

Vaccines that rely on mRNA technology like Pfizer and Moderna are 90% effective in preventing infections of the virus that causes covid-19 within two weeks of administering two doses, according to the first “real-world” study by the Centers for Disease Control and Prevention (CDC). Clinical trials had placed the vaccines’ effectiveness after two doses 4-5 percentage points higher. Still don’t know what mRNA vaccines do? We’ve got you covered.

A startup that used to focus on cancer is trying to build a vaccine that can confer immunity to mutant strains of covid-19. The company is Helix Nano and CNBC has more. We’re going to need something like it ASAP as epidemiologists warn mutations could render current vaccines ineffective in a year or less. A survey of 77 leading epidemiologists from 28 countries, carried out by the People’s Vaccine Alliance, found that two-thirds of the experts believe we have a year or less before the virus mutates to an extent where the majority of first-generation vaccines are rendered ineffective and new or modified vaccines are required, reports Relief Web.

Enterprise is a daily publication of Enterprise Ventures LLC, an Egyptian limited liability company (commercial register 83594), and a subsidiary of Inktank Communications. Summaries are intended for guidance only and are provided on an as-is basis; kindly refer to the source article in its original language prior to undertaking any action. Neither Enterprise Ventures nor its staff assume any responsibility or liability for the accuracy of the information contained in this publication, whether in the form of summaries or analysis. © 2022 Enterprise Ventures LLC.

Enterprise is available without charge thanks to the generous support of HSBC Egypt (tax ID: 204-901-715), the leading corporate and retail lender in Egypt; EFG Hermes (tax ID: 200-178-385), the leading financial services corporation in frontier emerging markets; SODIC (tax ID: 212-168-002), a leading Egyptian real estate developer; SomaBay (tax ID: 204-903-300), our Red Sea holiday partner; Infinity (tax ID: 474-939-359), the ultimate way to power cities, industries, and homes directly from nature right here in Egypt; CIRA (tax ID: 200-069-608), the leading providers of K-12 and higher level education in Egypt; Orascom Construction (tax ID: 229-988-806), the leading construction and engineering company building infrastructure in Egypt and abroad; Moharram & Partners (tax ID: 616-112-459), the leading public policy and government affairs partner; Palm Hills Developments (tax ID: 432-737-014), a leading developer of commercial and residential properties; Mashreq (tax ID: 204-898-862), the MENA region’s leading homegrown personal and digital bank; Industrial Development Group (IDG) (tax ID:266-965-253), the leading builder of industrial parks in Egypt; Hassan Allam Properties (tax ID:  553-096-567), one of Egypt’s most prominent and leading builders; and Saleh, Barsoum & Abdel Aziz (tax ID: 220-002-827), the leading audit, tax and accounting firm in Egypt.